Bill Snyder

February 27, 2026

‘Kindlins’ are a key to kidney formation

Kindlins regulate cell signaling during the formation of ureteric buds, a key step in the development of the kidneys’ urine collection system.

February 24, 2026

Vanderbilt University School of Medicine ranks seventh in NIH support of disease-fighting research

Six clinical departments and two basic science departments at VUSM ranked in the top 10 among medical school departments nationwide in fiscal year 2025.  

February 20, 2026

Ancient teeth, enduring patterns: Mummy study supports oral-cardiovascular disease link

CT scans of 37 Egyptian mummies found strong correlations between oral disease and calcified blood vessels, offering new evidence that the link between dental and cardiovascular health spans 4,000 years of human history.

C. difficile bacteria (image courtesy of CDC/Jennifer Oosthuizen)
February 18, 2026

Vanderbilt research offers new hope for preventing repeated C. diff infections

Treatment options are limited for the more than 500,000 people in the U.S. who are diagnosed annually with C. diff infections, but researchers are working on potential vaccines, therapeutic antibodies and — most recently — nanobodies, to prevent and treat C. diff infections.

(iStock)
February 13, 2026

Anti-Marburg antibody from Vanderbilt Health sent to Ethiopia during outbreak

There currently are no approved treatments or vaccines to protect against the infection, which can cause internal bleeding, organ failure, and in roughly 50% of cases, death.

February 11, 2026

Vaccination cuts risk of COVID-19 respiratory failure or death by 80%

Researchers at Vanderbilt Health and around the country continue to evaluate the effectiveness of vaccines approved by the Food and Drug Administration to reduce the severity and lethality of respiratory infections caused by the ever-mutating SARS-CoV-2 virus.